Special article
Use of the cardiovascular polypill 40mg in secondary cardiovascular prevention
Uso de la polipíldora cardiovascular 40mg en prevención cardiovascular secundaria
Domingo Marzala, Luis Rodríguez Padialb, Joan-Albert Arnáizc, Almudena Castrod, Juan Cosíne, Iñaki Lekuonaf, Carlos Guijarrog,
Corresponding author
a Hospital Virgen del Mar, Madrid, Spain
b Complejo Hospitalario Universitario de Toledo, Toledo, Spain
c Hospital Clínic, Barcelona, Spain
d Hospital Universitario La Paz, Madrid, Spain
e Hospital Arnau de Vilanova, Valencia, Spain
f Hospital Galdakao, Galdakao, Bizkaia, Spain
g Hospital Universitario Fundación Alcorcón, Universidad Rey Juan Carlos, Alcorcón, Madrid, Spain
Read
1574
Timeswas read the article
264
Total PDF
1310
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 20 | 18 | 38 |
| 2025 11 | 69 | 36 | 105 |
| 2025 10 | 51 | 20 | 71 |
| 2025 9 | 54 | 11 | 65 |
| 2025 8 | 38 | 16 | 54 |
| 2025 7 | 92 | 12 | 104 |
| 2025 6 | 55 | 8 | 63 |
| 2025 5 | 33 | 6 | 39 |
| 2025 4 | 24 | 4 | 28 |
| 2025 3 | 26 | 6 | 32 |
| 2025 2 | 26 | 2 | 28 |
| 2025 1 | 21 | 1 | 22 |
| 2024 12 | 18 | 1 | 19 |
| 2024 11 | 38 | 1 | 39 |
| 2024 10 | 10 | 0 | 10 |
| 2024 9 | 19 | 4 | 23 |
| 2024 8 | 18 | 0 | 18 |
| 2024 7 | 16 | 2 | 18 |
| 2024 6 | 16 | 0 | 16 |
| 2024 5 | 16 | 3 | 19 |
| 2024 4 | 22 | 5 | 27 |
| 2024 3 | 27 | 4 | 31 |
| 2024 2 | 22 | 4 | 26 |
| 2024 1 | 23 | 1 | 24 |
| 2023 12 | 16 | 4 | 20 |
| 2023 11 | 39 | 5 | 44 |
| 2023 10 | 30 | 2 | 32 |
| 2023 9 | 28 | 1 | 29 |
| 2023 8 | 25 | 0 | 25 |
| 2023 7 | 10 | 1 | 11 |
| 2023 6 | 30 | 3 | 33 |
| 2023 5 | 43 | 0 | 43 |
| 2023 4 | 78 | 0 | 78 |
| 2023 3 | 31 | 1 | 32 |
| 2023 2 | 22 | 4 | 26 |
| 2023 1 | 29 | 4 | 33 |
| 2022 12 | 18 | 4 | 22 |
| 2022 11 | 25 | 6 | 31 |
| 2022 10 | 14 | 4 | 18 |
| 2022 9 | 18 | 5 | 23 |
| 2022 8 | 14 | 8 | 22 |
| 2022 7 | 10 | 6 | 16 |
| 2022 6 | 16 | 5 | 21 |
| 2022 5 | 23 | 7 | 30 |
| 2022 4 | 18 | 11 | 29 |
| 2022 3 | 8 | 11 | 19 |
| 2022 2 | 11 | 3 | 14 |
| 2018 9 | 0 | 4 | 4 |
Show all